19 May 2013
Keywords: bayer, sole, contender, roche, otc, unit, although
Article | 28 June 2004
Although four private-equity companies may still be in the running to acquire Swiss drug major Roche's over-the-counter medicines business
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 June 2004
5 July 2004
17 May 2013
© 2013 thepharmaletter.com